Control of schistosomiasis relies on a single drug, praziquantel (PZQ). Given the rising
concerns about the potential emergence of PZQ-resistant strains, it has now become …

Background Schistosomiasis has been reported in 78 endemic countries and affects 240
million people worldwide. The digenetic parasite Schistosoma mansoni needs fresh water to …

Although great reductions in human schistosomiasis have been observed after praziquantel
(PZQ) mass drug administration (MDA), some individuals remain infected after multiple …

BACKGROUND Praziquantel has been cited as the only drug for treating schistosomiasis.
However, concerns over drug resistance have encouraged the search for novel drug leads …

Herein, innovative biocides are designed for the treatment of Trichinella spiralis muscle
larvae (ML) and adult worms. Samarium-doped ZnO nanorods (Sm-doped ZnO) are …

This original study suggests that alterations observed on tegumental structure and egg
quality of adult Schistosoma mansoni harvested from TS mice are due to their high immune …

Schistosomiasis is a neglected chronic parasitic disease with a significant lasting morbidity.
Currently, praziquantel (PZQ) is the most efficient drug for schistosomiasis worldwide …

Schistosomiasis is a neglected tropical disease caused by blood flukes of the genus
Schistosoma. This disease control has been widely made by praziquantel-reference drug …

Recent advances in molecular genetics and in imaging mean that it is now increasingly
feasible to image biological processes within helminth parasites and to visualize interactions …

Results: TS infected mice showed hepatosplenomegaly more intense (Figure 1A) and larger
size of hepatic granulomas (Figure 1B) than TR strain. When infected, both strains produced …